BioCell Technology announced the publication of a new clinical study on BioCell Collagen®. The study, now indexed on PubMed, describes the potential of BioCell Collagen for protecting the connective tissue of the musculoskeletal system and enhancing recovery from intense exercise. The randomized, double blind, placebo-controlled study was carried out by investigators at the Center for Applied Health Sciences (CAHS) who presented data in June at the 2014 International Society of Sports Nutrition (ISSN) Conference in Clearwater Beach, Fla.
Earlier clinical studies of BioCell Collagen have substantiated its safety and efficacy in promoting joint health and skin beauty. As these studies provide evidence that the patented healthy aging ingredient supports various connective tissues throughout the body, this proof-of-concept study was conducted to investigate whether daily intake of BioCell Collagen for six weeks could protect skeletal muscle connective tissue following an intense exercise challenge, and also enhance recovery. Data from the study showed that BioCell Collagen attenuated deleterious changes in muscle tissue damage and inflammatory biomarkers including creatine kinase, lactate dehydrogenase, and C-reactive protein. In addition, subjects who took BioCell Collagen appeared to show a more robust “repeated bout effect” as compared to placebo, suggesting augmented tissue recovery and remodeling.
“Extending its market-leading position as a key joint and skin health ingredient, this new clinical study in recreationally active healthy subjects provides intriguing dataset suggesting that this patented, research-backed dietary supplement has promising new applications in sports nutrition” says Suhail Ishaq, president of BioCell Technology, “This opens up a new category in sports nutrition regarding connective tissue protection and recovery from post-workout soreness and limiting repetitive, overuse related injuries.”
The details of the abstract are published in the JISSN website.